Bertrand Lebouché, MD, PhD - Bertrand Lebouché, MD, PhD - Research Institute MUHC
HIV care • biomedical HIV prevention • patient-reported outcomes • HIV screening • men who have sex with men
My research focuses on three main axes, drawing on a multidisciplinary model of care and a patient-oriented perspective. First of all, I study HIV/STI testing. Fifteen percent of PLHIV in Canada are undiagnosed. I examined the impact of a community-based rapid HIV-testing site with nurse and community agent teams on attracting vulnerable groups, linking them to care and service appreciation. Secondly, I study sexual health and antiretroviral therapy (ART) as prevention. Sexual health issues in HIV-positive MSM regularly go unaddressed. With parallel studies, I will examine the effect of a sex therapist-led intervention on their adherence, transmission risk, and broader sexual health. Thirdly, I study Optimizing ART. Innovative clinical monitoring tools are needed to detect factors that could interfere with ART adherence early. My I-Score Study will generate an electronic patient-reported outcome measure for use in routine HIV care towards more patient-centered care.
Engler, K., Rollet, K., Lessard, D., Thomas, R., & Lebouché, B. Ability of a rapid HIV testing site to attract and test vulnerable populations: a cross-sectional study on Actuel sur Rue. International Journal of STD & AIDS, submitted July 13, 2015, accepted July 22, 2015 (IJSA-15-241).
Lebouché, B., Engler, K., Machouf, N., Lessard, D., & Thomas, R. (accepted May 18, 2015). Predictors of interest in taking PrEP among MSM who used a rapid HIV-testing site in Montreal (Actuel sur Rue). HIV Medicine. PMID: 26177691.
Lessard, D., Lebouché, B., Engler, K., Thomas, R. & Machouf, N. (2015). Explaining the appeal for migrant MSM of a community-based rapid HIV-testing site in Montreal (Actuel sur Rue). AIDS Care. doi: 10.1080/09540121.2015.1028880. PMID: 25849524.
Lebouché, B., Engler, K., Lévy, J. J., Gilmore, N., Spire, B., Rozenbaum, W. & Routy, J.-P. (2013). Minimal interference: A basis for selecting ART for prevention with positives. AIDS Care, 25(10), 1284-90. doi: 10.1080/09540121.2013.764394. PMID: 23394079.
Lebouché, B., Engler, K., Lévy, J. J., Gilmore, N., Spire, B., Rozenbaum, W., Lacene, T. & Routy, J.-P. (2013). French HIV experts on early antiretroviral therapy for prevention: uncertainty and heterogeneity. Journal of the International Association of Providers of AIDS Care, 13 (2), 160-169. doi: 10.1177/2325957413488196. PMID: 23761218.